SlideShare uma empresa Scribd logo
1 de 6
Baixar para ler offline
Poland Diabetes Care Devices Investment Opportunities,
Analysis and Forecasts to 2018
Report Details:
Published:September 2012
No. of Pages: 69
Price: Single User License – US$2500




Poland Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018


Summary


Global Markets Direct’s new report, “Poland Diabetes Care Devices Investment Opportunities,
Analysis and Forecasts to 2018” provides key market data on the Poland Diabetes Care Devices
market. The report provides value (USD million), volume (units) and average price (USD) data for
each segment and sub-segment within two market categories – Glucose Monitoring and Insulin
Delivery. The report also provides company shares and distribution shares data for each of the
aforementioned market categories. The report is supplemented with global corporate-level profiles
of the key market participants with information on company financials and pipeline products,
wherever available.

This report is built using data and information sourced from proprietary databases, primary and
secondary research and in-house analysis by Global Markets Direct’s team of industry experts.


Scope


- Market size and company share data for Diabetes Care Devices market categories – Glucose
Monitoring and Insulin Delivery.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for
each of the segments and sub-segments within two market categories. Data from 2004 to 2011,
forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the two market categories.
- Global corporate-level profiles of key companies operating within the Poland Diabetes Care
Devices market.
- Key players covered include F. Hoffmann-La Roche Ltd., LifeScan, Inc., Bayer HealthCare AG,
Sanofi, Abbott Laboratories, Becton, Dickinson and Company and others.
Reasons to buy


- Develop business strategies by identifying the key market categories and segments poised for
strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Poland Diabetes Care
Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to
register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product
distribution – Identify, understand and capitalize.

Get your copy of this report @
http://www.reportsnreports.com/reports/195375-poland-diabetes-care-devices-investment-opportunities-analysis-
and-forecasts-to-2018.html

Major points covered in Table of Contents of this report include
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 What is This Report About? 7
3 Diabetes Care Devices In Poland 8
3.1 Diabetes Care Devices, Poland, Overall Revenue ($m), USD Constant, 2004-2018 8
3.2 Diabetes Care Devices, Poland, Company Share (2010-2011) 13
4 Glucose Monitoring In Poland 15
4.1 Glucose Monitoring Overall Revenue, (2004-2018) 15
4.1.1 Blood Glucose Meters, Revenue (2004-2018) 19
4.2 Glucose Monitoring Overall Volume (2004-2018) 23
4.2.1 Blood Glucose Meters, Volume (2004-2018) 27
4.3 Glucose Monitoring Average Price (2004-2018) 29
4.4 Glucose Monitoring Distribution Share (2010-2011) 30
4.5 Glucose Monitoring, Poland, Company Share (2010-2011) 31
5 Insulin Delivery In Poland 33
5.1 Insulin Delivery Overall Revenue, (2004-2018) 33
5.1.1 Insulin Pens, Revenue (2004-2018) 37
5.1.2 Insulin Pumps, Revenue (2004-2018) 41
5.2 Insulin Delivery Overall Volume (2004-2018) 43
5.2.1 Insulin Pens, Volume (2004-2018) 47
5.2.2 Insulin Pumps, Volume (2004-2018) 51
5.3 Insulin Delivery Average Price (2004-2018) 53
5.4 Insulin Delivery Distribution Share (2010-2011) 54
5.5 Insulin Delivery, Poland, Company Share (2010-2011) 55
6 Overview of Key Companies in Poland Diabetes Care Devices Market 57
6.1 F. Hoffmann-La Roche Ltd. 57
6.1.1 Company Overview 57
6.2 LifeScan, Inc. 57
6.2.1 Company Overview 57
6.3 Bayer HealthCare AG 58
6.3.1 Company Overview 58
6.4 Sanofi 58
6.4.1 Company Overview 58
6.5 Abbott Laboratories 59
6.5.1 Company Overview 59
6.6 Becton, Dickinson and Company 59
6.6.1 Company Overview 59
6.7 Eli Lilly and Company 60
6.7.1 Company Overview 60
6.8 Medtronic, Inc. 60
6.8.1 Company Overview 60
6.9 Novo Nordisk A/S 61
6.9.1 Company Overview 61
6.10 Terumo Corporation 61
6.10.1 Company Overview 61
6.11 Animas Corporation 62
6.11.1 Company Overview 62
6.12 Abbott Laboratories 62
6.12.1 Company Overview 62
6.13 Nipro Corporation 62
6.13.1 Company Overview 62
7 Appendix 63
7.1 Global Markets Direct Research Methodology 63
7.2 Definitions of Markets Covered in the Report 64
7.2.1 Diabetes Care Devices 64
7.3 Secondary Research 67
7.4 Primary Research 67
7.5 Models 68
7.6 Forecasts 68
7.7 Expert Panel Validation 68
7.8 Currency Conversion 69
7.9 Contact Us 69
7.10 Disclaimer 69


1.1 List of Tables
Table 1: Diabetes Care Devices, Poland, Overall Revenue ($m), USD Constant, 2004-2018 8
Table 2: Diabetes Care Devices, Poland, Overall Revenue ($m), USD Constant, Historic, 2004-
2011 10
Table 3: Diabetes Care Devices, Poland, Overall Revenue ($m), USD Constant, Forecast, 2011-
2018 12
Table 4: Diabetes Care Devices, Poland, Company Share by Revenue ($m), USD Constant, 2010-
2011 14
Table 5: Glucose Monitoring, Poland, Revenue ($m) USD Constant, by Segment, Historic, 2004-
2011 16
Table 6: Glucose Monitoring, Poland, Revenue ($m) USD Constant, by Segment, Forecast, 2011-
2018 18
Table 7: Blood Glucose Meters, Poland, Revenue ($m) USD Constant, by Sub-Segment, Historic,
2004-2011 20
Table 8: Blood Glucose Meters, Poland, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 22
Table 9: Glucose Monitoring, Poland, Volume (Units) by Segment, Historic, 2004-2011 24
Table 10: Glucose Monitoring, Poland, Volume (Units) by Segment, Forecast, 2011-2018 26
Table 11: Blood Glucose Meters, Poland, Volume (Units) by Sub-Segment, Historic, 2004-2011 27
Table 12: Blood Glucose Meters, Poland, Volume (Units) by Sub-Segment, Forecast, 2011-2018
28
Table 13: Glucose Monitoring, Poland, Average Price ($), Historic, 2004-2011 29
Table 14: Glucose Monitoring, Poland, Average Price ($), Forecast, 2011-2018 29
Table 15: Glucose Monitoring, Poland, Distribution Share by Revenue ($m), USD Constant, 2010-
2011 30
Table 16: Glucose Monitoring, Poland, Company Share by Revenue ($m), USD Constant, 2010-
2011 32
Table 17: Insulin Delivery, Poland, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
34
Table 18: Insulin Delivery, Poland, Revenue ($m) USD Constant, by Segment, Forecast, 2011-
2018 36
Table 19: Insulin Pens, Poland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-
2011 38
Table 20: Insulin Pens, Poland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-
2018 40
Table 21: Insulin Pumps (Traditional Insulin Pumps), Poland, Revenue ($m) USD Constant,
Historic, 2004-2011 41
Table 22: Insulin Pumps (Traditional Insulin Pumps), Poland, Revenue ($m) USD Constant,
Forecast, 2011-2018 42
Table 23: Insulin Delivery, Poland, Volume (Units) by Segment, Historic, 2004-2011 44
Table 24: Insulin Delivery, Poland, Volume (Units) by Segment, Forecast, 2011-2018 46
Table 25: Insulin Pens, Poland, Volume (Units) by Sub-Segment, Historic, 2004-2011 48
Table 26: Insulin Pens, Poland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 50
Table 27: Insulin Pumps (Traditional Insulin Pumps), Poland, Volume (Units), Historic, 2004-2011
51
Table 28: Insulin Pumps (Traditional Insulin Pumps), Poland, Volume (Units), Forecast, 2011-2018
52
Table 29: Insulin Delivery, Poland, Average Price ($), Historic, 2004-2011 53
Table 30: Insulin Delivery, Poland, Average Price ($), Forecast, 2011-2018 53
Table 31: Insulin Delivery, Poland, Distribution Share by Revenue ($m), USD Constant, 2010-
2011 54
Table 32: Insulin Delivery, Poland, Company Share by Revenue ($m), USD Constant, 2010-2011
56


1.2 List of Figures
Figure 1: Diabetes Care Devices, Poland, Overall Revenue ($m), USD Constant, 2004-2018 8
Figure 2: Diabetes Care Devices, Poland, Overall Revenue ($m), USD Constant, Historic, 2004-
2011 9
Figure 3: Diabetes Care Devices, Poland, Overall Revenue ($m), USD Constant, Forecast, 2011-
2018 11
Figure 4: Diabetes Care Devices, Poland, Company Share (%), 2011 13
Figure 5: Glucose Monitoring, Poland, Revenue ($m) USD Constant, by Segment, Historic, 2004-
2011 15
Figure 6: Glucose Monitoring, Poland, Revenue ($m) USD Constant, by Segment, Forecast, 2011-
2018 17
Figure 7: Blood Glucose Meters, Poland, Revenue ($m) USD Constant, by Sub-Segment, Historic,
2004-2011 19
Figure 8: Blood Glucose Meters, Poland, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 21
Figure 9: Glucose Monitoring, Poland, Volume (Units) by Segment, Historic, 2004-2011 23
Figure 10: Glucose Monitoring, Poland, Volume (Units) by Segment, Forecast, 2011-2018 25
Figure 11: Blood Glucose Meters, Poland, Volume (Units) by Sub-Segment, Historic, 2004-2011
27
Figure 12: Blood Glucose Meters, Poland, Volume (Units) by Sub-Segment, Forecast, 2011-2018
28
Figure 13: Glucose Monitoring, Poland, Company Share (%), 2011 31
Figure 14: Insulin Delivery, Poland, Revenue ($m) USD Constant, by Segment, Historic, 2004-
2011 33
Figure 15: Insulin Delivery, Poland, Revenue ($m) USD Constant, by Segment, Forecast, 2011-
2018 35
Figure 16: Insulin Pens, Poland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-
2011 37
Figure 17: Insulin Pens, Poland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-
2018 39
Figure 18: Insulin Pumps (Traditional Insulin Pumps), Poland, Revenue ($m) USD Constant,
Historic, 2004-2011 41
Figure 19: Insulin Pumps (Traditional Insulin Pumps), Poland, Revenue ($m) USD Constant,
Forecast, 2011-2018 42
Figure 20: Insulin Delivery, Poland, Volume (Units) by Segment, Historic, 2004-2011 43
Figure 21: Insulin Delivery, Poland, Volume (Units) by Segment, Forecast, 2011-2018 45
Figure 22: Insulin Pens, Poland, Volume (Units) by Sub-Segment, Historic, 2004-2011 47
Figure 23: Insulin Pens, Poland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 49
Figure 24: Insulin Pumps (Traditional Insulin Pumps), Poland, Volume (Units), Historic, 2004-2011
51
Figure 25: Insulin Pumps (Traditional Insulin Pumps), Poland, Volume (Units), Forecast, 2011-
2018 52
Figure 26: Insulin Delivery, Poland, Company Share (%), 2011 55
Figure 27: Global Markets Direct Methodology 63
Contact: sales@reportsandreports.com for more information.

Mais conteúdo relacionado

Destaque

UCSF Informatics Day 2014 - Dana Ludwig, "Research Data Browser"
UCSF Informatics Day 2014 - Dana Ludwig, "Research Data Browser"UCSF Informatics Day 2014 - Dana Ludwig, "Research Data Browser"
UCSF Informatics Day 2014 - Dana Ludwig, "Research Data Browser"CTSI at UCSF
 
Ireland Anesthesia and Respiratory Devices Investment Opportunities, Analysis...
Ireland Anesthesia and Respiratory Devices Investment Opportunities, Analysis...Ireland Anesthesia and Respiratory Devices Investment Opportunities, Analysis...
Ireland Anesthesia and Respiratory Devices Investment Opportunities, Analysis...ReportsnReports
 
UCSF CER - Comparative Effectiveness Program (Symposium 2013)
UCSF CER - Comparative Effectiveness Program (Symposium 2013)UCSF CER - Comparative Effectiveness Program (Symposium 2013)
UCSF CER - Comparative Effectiveness Program (Symposium 2013)CTSI at UCSF
 
A 3-screen approach to Web performance optimization
A 3-screen approach to Web performance optimizationA 3-screen approach to Web performance optimization
A 3-screen approach to Web performance optimizationKeynote Mobile Testing
 
Argentina In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Gen...
Argentina In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Gen...Argentina In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Gen...
Argentina In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Gen...ReportsnReports
 
AFCPE 2013-The Culture of Personal Finance-What Financial Practitioners Need ...
AFCPE 2013-The Culture of Personal Finance-What Financial Practitioners Need ...AFCPE 2013-The Culture of Personal Finance-What Financial Practitioners Need ...
AFCPE 2013-The Culture of Personal Finance-What Financial Practitioners Need ...Barbara O'Neill
 

Destaque (8)

3637 5191-1-sm
3637 5191-1-sm3637 5191-1-sm
3637 5191-1-sm
 
UCSF Informatics Day 2014 - Dana Ludwig, "Research Data Browser"
UCSF Informatics Day 2014 - Dana Ludwig, "Research Data Browser"UCSF Informatics Day 2014 - Dana Ludwig, "Research Data Browser"
UCSF Informatics Day 2014 - Dana Ludwig, "Research Data Browser"
 
Ireland Anesthesia and Respiratory Devices Investment Opportunities, Analysis...
Ireland Anesthesia and Respiratory Devices Investment Opportunities, Analysis...Ireland Anesthesia and Respiratory Devices Investment Opportunities, Analysis...
Ireland Anesthesia and Respiratory Devices Investment Opportunities, Analysis...
 
UCSF CER - Comparative Effectiveness Program (Symposium 2013)
UCSF CER - Comparative Effectiveness Program (Symposium 2013)UCSF CER - Comparative Effectiveness Program (Symposium 2013)
UCSF CER - Comparative Effectiveness Program (Symposium 2013)
 
A 3-screen approach to Web performance optimization
A 3-screen approach to Web performance optimizationA 3-screen approach to Web performance optimization
A 3-screen approach to Web performance optimization
 
Ad watch
Ad watchAd watch
Ad watch
 
Argentina In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Gen...
Argentina In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Gen...Argentina In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Gen...
Argentina In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Gen...
 
AFCPE 2013-The Culture of Personal Finance-What Financial Practitioners Need ...
AFCPE 2013-The Culture of Personal Finance-What Financial Practitioners Need ...AFCPE 2013-The Culture of Personal Finance-What Financial Practitioners Need ...
AFCPE 2013-The Culture of Personal Finance-What Financial Practitioners Need ...
 

Poland Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018

  • 1. Poland Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018 Report Details: Published:September 2012 No. of Pages: 69 Price: Single User License – US$2500 Poland Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018 Summary Global Markets Direct’s new report, “Poland Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018” provides key market data on the Poland Diabetes Care Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct’s team of industry experts. Scope - Market size and company share data for Diabetes Care Devices market categories – Glucose Monitoring and Insulin Delivery. - Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within two market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018. - 2011 company shares and distribution shares data for each of the two market categories. - Global corporate-level profiles of key companies operating within the Poland Diabetes Care Devices market. - Key players covered include F. Hoffmann-La Roche Ltd., LifeScan, Inc., Bayer HealthCare AG, Sanofi, Abbott Laboratories, Becton, Dickinson and Company and others.
  • 2. Reasons to buy - Develop business strategies by identifying the key market categories and segments poised for strong growth. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the Poland Diabetes Care Devices competitive landscape. - Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize. Get your copy of this report @ http://www.reportsnreports.com/reports/195375-poland-diabetes-care-devices-investment-opportunities-analysis- and-forecasts-to-2018.html Major points covered in Table of Contents of this report include 1 Table of Contents 1 Table of Contents 2 1.1 List of Tables 5 1.2 List of Figures 6 2 Introduction 7 2.1 What is This Report About? 7 3 Diabetes Care Devices In Poland 8 3.1 Diabetes Care Devices, Poland, Overall Revenue ($m), USD Constant, 2004-2018 8 3.2 Diabetes Care Devices, Poland, Company Share (2010-2011) 13 4 Glucose Monitoring In Poland 15 4.1 Glucose Monitoring Overall Revenue, (2004-2018) 15 4.1.1 Blood Glucose Meters, Revenue (2004-2018) 19 4.2 Glucose Monitoring Overall Volume (2004-2018) 23 4.2.1 Blood Glucose Meters, Volume (2004-2018) 27 4.3 Glucose Monitoring Average Price (2004-2018) 29 4.4 Glucose Monitoring Distribution Share (2010-2011) 30 4.5 Glucose Monitoring, Poland, Company Share (2010-2011) 31 5 Insulin Delivery In Poland 33 5.1 Insulin Delivery Overall Revenue, (2004-2018) 33 5.1.1 Insulin Pens, Revenue (2004-2018) 37 5.1.2 Insulin Pumps, Revenue (2004-2018) 41 5.2 Insulin Delivery Overall Volume (2004-2018) 43 5.2.1 Insulin Pens, Volume (2004-2018) 47 5.2.2 Insulin Pumps, Volume (2004-2018) 51 5.3 Insulin Delivery Average Price (2004-2018) 53 5.4 Insulin Delivery Distribution Share (2010-2011) 54
  • 3. 5.5 Insulin Delivery, Poland, Company Share (2010-2011) 55 6 Overview of Key Companies in Poland Diabetes Care Devices Market 57 6.1 F. Hoffmann-La Roche Ltd. 57 6.1.1 Company Overview 57 6.2 LifeScan, Inc. 57 6.2.1 Company Overview 57 6.3 Bayer HealthCare AG 58 6.3.1 Company Overview 58 6.4 Sanofi 58 6.4.1 Company Overview 58 6.5 Abbott Laboratories 59 6.5.1 Company Overview 59 6.6 Becton, Dickinson and Company 59 6.6.1 Company Overview 59 6.7 Eli Lilly and Company 60 6.7.1 Company Overview 60 6.8 Medtronic, Inc. 60 6.8.1 Company Overview 60 6.9 Novo Nordisk A/S 61 6.9.1 Company Overview 61 6.10 Terumo Corporation 61 6.10.1 Company Overview 61 6.11 Animas Corporation 62 6.11.1 Company Overview 62 6.12 Abbott Laboratories 62 6.12.1 Company Overview 62 6.13 Nipro Corporation 62 6.13.1 Company Overview 62 7 Appendix 63 7.1 Global Markets Direct Research Methodology 63 7.2 Definitions of Markets Covered in the Report 64 7.2.1 Diabetes Care Devices 64 7.3 Secondary Research 67 7.4 Primary Research 67 7.5 Models 68 7.6 Forecasts 68 7.7 Expert Panel Validation 68 7.8 Currency Conversion 69 7.9 Contact Us 69 7.10 Disclaimer 69 1.1 List of Tables
  • 4. Table 1: Diabetes Care Devices, Poland, Overall Revenue ($m), USD Constant, 2004-2018 8 Table 2: Diabetes Care Devices, Poland, Overall Revenue ($m), USD Constant, Historic, 2004- 2011 10 Table 3: Diabetes Care Devices, Poland, Overall Revenue ($m), USD Constant, Forecast, 2011- 2018 12 Table 4: Diabetes Care Devices, Poland, Company Share by Revenue ($m), USD Constant, 2010- 2011 14 Table 5: Glucose Monitoring, Poland, Revenue ($m) USD Constant, by Segment, Historic, 2004- 2011 16 Table 6: Glucose Monitoring, Poland, Revenue ($m) USD Constant, by Segment, Forecast, 2011- 2018 18 Table 7: Blood Glucose Meters, Poland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 20 Table 8: Blood Glucose Meters, Poland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 22 Table 9: Glucose Monitoring, Poland, Volume (Units) by Segment, Historic, 2004-2011 24 Table 10: Glucose Monitoring, Poland, Volume (Units) by Segment, Forecast, 2011-2018 26 Table 11: Blood Glucose Meters, Poland, Volume (Units) by Sub-Segment, Historic, 2004-2011 27 Table 12: Blood Glucose Meters, Poland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 28 Table 13: Glucose Monitoring, Poland, Average Price ($), Historic, 2004-2011 29 Table 14: Glucose Monitoring, Poland, Average Price ($), Forecast, 2011-2018 29 Table 15: Glucose Monitoring, Poland, Distribution Share by Revenue ($m), USD Constant, 2010- 2011 30 Table 16: Glucose Monitoring, Poland, Company Share by Revenue ($m), USD Constant, 2010- 2011 32 Table 17: Insulin Delivery, Poland, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 34 Table 18: Insulin Delivery, Poland, Revenue ($m) USD Constant, by Segment, Forecast, 2011- 2018 36 Table 19: Insulin Pens, Poland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004- 2011 38 Table 20: Insulin Pens, Poland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011- 2018 40 Table 21: Insulin Pumps (Traditional Insulin Pumps), Poland, Revenue ($m) USD Constant, Historic, 2004-2011 41 Table 22: Insulin Pumps (Traditional Insulin Pumps), Poland, Revenue ($m) USD Constant, Forecast, 2011-2018 42 Table 23: Insulin Delivery, Poland, Volume (Units) by Segment, Historic, 2004-2011 44 Table 24: Insulin Delivery, Poland, Volume (Units) by Segment, Forecast, 2011-2018 46 Table 25: Insulin Pens, Poland, Volume (Units) by Sub-Segment, Historic, 2004-2011 48 Table 26: Insulin Pens, Poland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 50
  • 5. Table 27: Insulin Pumps (Traditional Insulin Pumps), Poland, Volume (Units), Historic, 2004-2011 51 Table 28: Insulin Pumps (Traditional Insulin Pumps), Poland, Volume (Units), Forecast, 2011-2018 52 Table 29: Insulin Delivery, Poland, Average Price ($), Historic, 2004-2011 53 Table 30: Insulin Delivery, Poland, Average Price ($), Forecast, 2011-2018 53 Table 31: Insulin Delivery, Poland, Distribution Share by Revenue ($m), USD Constant, 2010- 2011 54 Table 32: Insulin Delivery, Poland, Company Share by Revenue ($m), USD Constant, 2010-2011 56 1.2 List of Figures Figure 1: Diabetes Care Devices, Poland, Overall Revenue ($m), USD Constant, 2004-2018 8 Figure 2: Diabetes Care Devices, Poland, Overall Revenue ($m), USD Constant, Historic, 2004- 2011 9 Figure 3: Diabetes Care Devices, Poland, Overall Revenue ($m), USD Constant, Forecast, 2011- 2018 11 Figure 4: Diabetes Care Devices, Poland, Company Share (%), 2011 13 Figure 5: Glucose Monitoring, Poland, Revenue ($m) USD Constant, by Segment, Historic, 2004- 2011 15 Figure 6: Glucose Monitoring, Poland, Revenue ($m) USD Constant, by Segment, Forecast, 2011- 2018 17 Figure 7: Blood Glucose Meters, Poland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 19 Figure 8: Blood Glucose Meters, Poland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 21 Figure 9: Glucose Monitoring, Poland, Volume (Units) by Segment, Historic, 2004-2011 23 Figure 10: Glucose Monitoring, Poland, Volume (Units) by Segment, Forecast, 2011-2018 25 Figure 11: Blood Glucose Meters, Poland, Volume (Units) by Sub-Segment, Historic, 2004-2011 27 Figure 12: Blood Glucose Meters, Poland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 28 Figure 13: Glucose Monitoring, Poland, Company Share (%), 2011 31 Figure 14: Insulin Delivery, Poland, Revenue ($m) USD Constant, by Segment, Historic, 2004- 2011 33 Figure 15: Insulin Delivery, Poland, Revenue ($m) USD Constant, by Segment, Forecast, 2011- 2018 35 Figure 16: Insulin Pens, Poland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004- 2011 37 Figure 17: Insulin Pens, Poland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011- 2018 39 Figure 18: Insulin Pumps (Traditional Insulin Pumps), Poland, Revenue ($m) USD Constant,
  • 6. Historic, 2004-2011 41 Figure 19: Insulin Pumps (Traditional Insulin Pumps), Poland, Revenue ($m) USD Constant, Forecast, 2011-2018 42 Figure 20: Insulin Delivery, Poland, Volume (Units) by Segment, Historic, 2004-2011 43 Figure 21: Insulin Delivery, Poland, Volume (Units) by Segment, Forecast, 2011-2018 45 Figure 22: Insulin Pens, Poland, Volume (Units) by Sub-Segment, Historic, 2004-2011 47 Figure 23: Insulin Pens, Poland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 49 Figure 24: Insulin Pumps (Traditional Insulin Pumps), Poland, Volume (Units), Historic, 2004-2011 51 Figure 25: Insulin Pumps (Traditional Insulin Pumps), Poland, Volume (Units), Forecast, 2011- 2018 52 Figure 26: Insulin Delivery, Poland, Company Share (%), 2011 55 Figure 27: Global Markets Direct Methodology 63 Contact: sales@reportsandreports.com for more information.